{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T16:52:33Z","timestamp":1770483153749,"version":"3.49.0"},"reference-count":65,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1586\/erv.11.32","type":"journal-article","created":{"date-parts":[[2011,5,23]],"date-time":"2011-05-23T16:05:57Z","timestamp":1306166757000},"page":"575-588","source":"Crossref","is-referenced-by-count":31,"title":["A combination recombinant protein and outer membrane vesicle vaccine against serogroup B meningococcal disease"],"prefix":"10.1586","volume":"10","author":[{"given":"Ee Lyn","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew D","family":"Snape","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,1,9]]},"reference":[{"key":"CIT0001","doi-asserted-by":"crossref","first-page":"B51","DOI":"10.1016\/j.vaccine.2009.04.063","volume":"27","author":"Harrison","year":"2009","journal-title":"Vaccine"},{"key":"CIT0002","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.4049\/jimmunol.138.12.4402","volume":"138","author":"Finne","year":"1987","journal-title":"J. Immunol."},{"key":"CIT0003","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/infdis\/171.6.1481","volume":"171","author":"Hayrinen","year":"1995","journal-title":"J. Infect. Dis."},{"key":"CIT0004","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1084\/jem.138.5.1156","volume":"138","author":"Devoe","year":"1973","journal-title":"J. Exp. Med."},{"key":"CIT0005","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1586\/erv.09.30","volume":"8","author":"Lewis","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"CIT0006","first-page":"67","volume":"14","author":"Fredriksen","year":"1991","journal-title":"NIPH Ann."},{"key":"CIT0007","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1086\/648966","volume":"50","author":"Granoff","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"CIT0008","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1590\/S0074-02761999000400002","volume":"94","author":"Rodriguez","year":"1999","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"CIT0009","first-page":"125","volume":"14","author":"Bjune","year":"1991","journal-title":"NIPH Ann."},{"key":"CIT0010","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.vaccine.2005.12.059","volume":"25","author":"Taha","year":"2007","journal-title":"Vaccine"},{"key":"CIT0011","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/ije\/dyn228","volume":"38","author":"Galloway","year":"2009","journal-title":"Int. J. Epidemiol."},{"key":"CIT0012","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1128\/CVI.13.4.486-491.2006","volume":"13","author":"Martin","year":"2006","journal-title":"Clin. Vaccine Immunol."},{"key":"CIT0013","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jama.281.16.1520","volume":"281","author":"Tappero","year":"1999","journal-title":"JAMA"},{"key":"CIT0014","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/INF.0b013e318195205e","volume":"28","author":"Wong","year":"2009","journal-title":"Pediatr. Infect. Dis. J."},{"key":"CIT0015","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1128\/JCM.38.9.3323-3328.2000","volume":"38","author":"Tondella","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"CIT0016","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1099\/jmm.0.46288-0","volume":"55","author":"Gray","year":"2006","journal-title":"J. Med. Microbiol."},{"key":"CIT0017","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1016\/j.vaccine.2007.01.023","volume":"25","author":"Oster","year":"2007","journal-title":"Vaccine"},{"key":"CIT0018","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1128\/IAI.60.8.3156-3161.1992","volume":"60","author":"van der Ley","year":"1992","journal-title":"Infect. Immun."},{"key":"CIT0019","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/0264-410X(96)00020-5","volume":"14","author":"Claassen","year":"1996","journal-title":"Vaccine"},{"key":"CIT0020","unstructured":"van den Dobbelsteen G, van Dijken H, Hamstra Het al.From HexaMen to NonaMen: expanding a multivalent PorA-based meningococcal outer membrane vesicle vaccine.Programs and Abstracts of the 14th International Pathogenic Neisseria Conference.Milwaukee, WI, USA (2004) (Abstract P153)."},{"key":"CIT0021","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1128\/CVI.00230-06","volume":"14","author":"Boutriau","year":"2007","journal-title":"Clin. Vaccine Immunol."},{"key":"CIT0022","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1016\/j.vaccine.2005.01.055","volume":"23","author":"Gorringe","year":"2005","journal-title":"Vaccine"},{"key":"CIT0023","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1128\/CVI.00118-09","volume":"16","author":"Gorringe","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"key":"CIT0024","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.vaccine.2010.12.039","volume":"29","author":"Keiser","year":"2011","journal-title":"Vaccine"},{"key":"CIT0025","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4049\/jimmunol.177.1.501","volume":"177","author":"Madico","year":"2006","journal-title":"J. Immunol."},{"key":"CIT0026","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.20021911","volume":"197","author":"Masignani","year":"2003","journal-title":"J. Exp. Med."},{"key":"CIT0027","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1128\/IAI.72.4.2088-2100.2004","volume":"72","author":"Fletcher","year":"2004","journal-title":"Infect. Immun."},{"key":"CIT0028","doi-asserted-by":"crossref","first-page":"I46","DOI":"10.1016\/j.vaccine.2008.11.068","volume":"26","author":"Pizza","year":"2008","journal-title":"Vaccine"},{"key":"CIT0029","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","volume":"344","author":"Walport","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"CIT0030","doi-asserted-by":"crossref","first-page":"7566","DOI":"10.4049\/jimmunol.176.12.7566","volume":"176","author":"Schneider","year":"2006","journal-title":"J. Immunol."},{"key":"CIT0031","unstructured":"Rappuoli R. Meningococcal biology and vaccines: ten years of genomics and reverse vaccinology.Programs and Abstracts of the 17th International Pathogenic Neisseria Conference.Banff, Canada (2010) (Abstract VW02)."},{"key":"CIT0032","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1086\/514821","volume":"195","author":"Beernink","year":"2007","journal-title":"J. Infect. Dis."},{"key":"CIT0033","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.vaccine.2009.12.027","volume":"28","author":"Pajon","year":"2010","journal-title":"Vaccine"},{"key":"CIT0034","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1016\/j.vaccine.2009.02.098","volume":"27","author":"Bambini","year":"2009","journal-title":"Vaccine"},{"key":"CIT0035","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1128\/CVI.00097-06","volume":"13","author":"Beernink","year":"2006","journal-title":"Clin. Vaccine Immunol."},{"key":"CIT0036","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1128\/CVI.00027-10","volume":"17","author":"Lucidarme","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"CIT0037","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1016\/j.vaccine.2010.06.083","volume":"28","author":"Jiang","year":"2010","journal-title":"Vaccine"},{"key":"CIT0038","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1016\/j.vaccine.2009.01.075","volume":"27","author":"McNeil","year":"2009","journal-title":"Vaccine"},{"key":"CIT0039","unstructured":"Richmond P, Marshall H, Sheldon Eet al.Safety & immunogenicity of serogroup BNeisseria meningitidis(MnB) rLP2086 vaccine in adults and adolescent subjects: overview of 3 clinical trials.Programs and Abstracts of the 17th International Pathogenic Neisseria Conference.Banff, Canada (2010) (Abstract VW04)."},{"key":"CIT0040","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","volume":"287","author":"Pizza","year":"2000","journal-title":"Science"},{"key":"CIT0041","doi-asserted-by":"crossref","first-page":"10834","DOI":"10.1073\/pnas.0603940103","volume":"103","author":"Giuliani","year":"2006","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"CIT0042","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1084\/jem.20020407","volume":"195","author":"Comanducci","year":"2002","journal-title":"J. Exp. Med."},{"key":"CIT0043","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-2958.2004.04423.x","volume":"55","author":"Capecchi","year":"2005","journal-title":"Mol. Microbiol."},{"key":"CIT0044","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1128\/IAI.72.7.4217-4223.2004","volume":"72","author":"Comanducci","year":"2004","journal-title":"Infect. Immun."},{"key":"CIT0045","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1128\/JCM.00936-09","volume":"47","author":"Lucidarme","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"CIT0046","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1073\/pnas.0915162107","volume":"107","author":"Serruto","year":"2010","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"CIT0047","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1086\/379375","volume":"188","author":"Welsch","year":"2003","journal-title":"J. Infect. Dis."},{"key":"CIT0048","unstructured":"Holst J, Bambine S, Muzzi Aet al.Sequence variation and degree of expression for five genome-derived vaccine antigens included in the MenB Novartis investigational vaccine.Programs and Abstracts of the 17th International Pathogenic Neisseria Conference.Banff, Canada (2010) (Abstract P047)."},{"key":"CIT0049","unstructured":"Wang X, Cohn A, Comanducci Met al.Prevalence and genetic diversity of candidate vaccine antigens among invasiveNeisseria meningitidisisolates in the United States.Programs and Abstracts of the 17th International Pathogenic Neisseria Conference.Banff, Canada (2010) (Abstract P089)."},{"key":"CIT0050","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1097\/INF.0b013e3181faa6be","volume":"29","author":"Snape","year":"2010","journal-title":"Pediatr. Infect. Dis. J."},{"key":"CIT0051","unstructured":"Dull P, Kimura A, Vienken Ket al.Phase III formulation development of recombinant meningococcal B vaccine (rMenB) containing fHbp, NHBA, NadA, and New Zealand (NZ98\/254) outer membrane vesicles (OMV).Programs and Abstracts of the 28th Annual Meeting of the European Society for Paediatric Infectious Diseases.Nice, France (2010) (Poster)."},{"key":"CIT0052","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1128\/CVI.00304-10","volume":"18","author":"Kimura","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"CIT0053","doi-asserted-by":"crossref","first-page":"19490","DOI":"10.1073\/pnas.1013758107","volume":"107","author":"Donnelly","year":"2010","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"CIT0054","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1016\/j.vaccine.2006.03.091","volume":"24","author":"Borrow","year":"2006","journal-title":"Vaccine"},{"key":"CIT0055","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1086\/656741","volume":"51","author":"Findlow","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"CIT0056","unstructured":"Vesikari T, Esposito S, Kimura Aet al.Immunogenicity of an investigational multicomponent meningococcal serogroup B vaccine in healthy infants at 2, 4 and 6 months of age.Programs and Abstracts of the 17th International Pathogenic Neisseria Conference.Banff, Canada (2010) (Abstract P180)."},{"key":"CIT0057","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.vaccine.2010.11.064","volume":"29","author":"Brunelli","year":"2011","journal-title":"Vaccine"},{"key":"CIT0058","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1016\/j.vaccine.2010.05.014","volume":"28","author":"Giuliani","year":"2010","journal-title":"Vaccine"},{"key":"CIT0059","unstructured":"Biolchi A, Kleinschmidt A, Boccadifuoco Get al.Evaluation of the contribution of protein antigen NHBA to bactericidal antibody responses in sera from human vaccinees enrolled in clinical trials.Programs and Abstracts of the 17th International Pathogenic Neisseria Conference.Banff, Canada (2010) (Abstract P188)."},{"key":"CIT0060","unstructured":"Esposito S, Vesikari T, Kimura Aet al.Tolerability of a three-dose schedule of an investigational, multicomponent meningococcal serogroup B vaccine and routine infant vaccines in a lot consistency trial.Programs and Abstracts of the 17th International Pathogenic Neisseria Conference.Banff, Canada (2010) (Abstract P182)."},{"key":"CIT0061","unstructured":"Brunelli B, Tordello E, Palumbo Eet al.Evaluation of the cross protective capabilities of theNeisseria meningitidisfHbp antigen subvariant 1.1 through the generation of engineered meningococcal strains.Programs and Abstracts of the 17th International Pathogenic Neisseria Conference.Banff, Canada (2010) (Abstract P205)."},{"key":"CIT0062","doi-asserted-by":"crossref","first-page":"19490","DOI":"10.1073\/pnas.1013758107","volume":"107","author":"Donnelly","year":"2010","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"CIT0063","unstructured":"Plikaytis B, Stella M, Toti Set al.Interlaboratory standardization of the MATS ELISA: a protein antigen phenotyping method forN. meningitidisserogroup B.Programs and Abstracts of the 17th International Pathogenic Neisseria Conference.Banff, Canada (2010) (Abstract P196)."},{"key":"CIT0064","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1086\/428590","volume":"191","author":"Claus","year":"2005","journal-title":"J. Infect. Dis."},{"key":"CIT0065","unstructured":"Christensen H, Trotter C, Hickman M, Edmunds W. Modelling the cost\u2013effectiveness of new meningococcal vaccines in England.Programs and Abstracts of the 17th International Pathogenic Neisseria Conference.Banff, Canada (2010) (Abstract OM08)."}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/erv.11.32","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T23:52:10Z","timestamp":1686095530000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1586\/erv.11.32"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":65,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,1,9]]},"published-print":{"date-parts":[[2011,5]]}},"alternative-id":["10.1586\/erv.11.32"],"URL":"https:\/\/doi.org\/10.1586\/erv.11.32","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}